glucose, (beta-d)-isomer has been researched along with Psoriasis in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (37.14) | 18.7374 |
| 1990's | 1 (2.86) | 18.2507 |
| 2000's | 2 (5.71) | 29.6817 |
| 2010's | 10 (28.57) | 24.3611 |
| 2020's | 9 (25.71) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, DK; Jeon, BH; Jo, EK; Kim, CD; Kim, JM; Kim, KK; Lee, HM; Lee, JH; Liang, ZL; Shin, DM; Yang, CS; Yuk, JM | 1 |
| Adams, M; Baillie, GS; Bartlett, JB; Capone, L; Cheung, YF; Gandhi, AK; Gilhar, A; Houslay, MD; Loveland, MA; Man, HW; Muller, GW; Parton, A; Schafer, PH; Stirling, DI; Wu, L | 1 |
| Bergstresser, PR; Hurd, ER; Sedgwick, JB | 1 |
| Altmeyer, P; Lemmel, EM; Schopf, RE | 1 |
| Chambers, DA; Jederberg, WW; Krueger, GG; Stubbs, JD; Torres, AR | 1 |
| Borregaard, N; Herlin, T | 1 |
| Csató, M; Dobozy, A; Hunyadi, J; Kenderessy, SA; Simon, N | 1 |
| Bussa, S; De Simone, C; De Sole, P; Fresu, R; Guerriero, C; Rumi, C; Venier, A | 1 |
| Kapp, A; Schöpf, E | 1 |
| Cerimele, D; De Simone, C; De Sole, P; Di Mario, G; Serri, F; Venier, A | 1 |
| Battoccoli, E; Marchiseppe, I; Offidani, AM; Simonetti, O; Tappa, MM; Valentino, M | 1 |
| Bloomfield, FJ; Young, MM | 1 |
| Glinski, W; Jablonska, S; Janczura, E; Tigalonowa, M | 1 |
| Hatzis, J; Panteleos, D; Tosca, A; Varelzidis, A | 1 |
| Schopf, RE; Straussfeld, E | 1 |
| Morsches, B; Schopf, RE; Straussfeld, E | 1 |
| Cheng, S; Ding, X; Wang, D; Zou, G | 1 |
| Alipieva, K; Balcheva-Sivenova, ZP; Ferrante, C; Georgiev, MI; Koycheva, IK; Mihaylova, LV; Orlando, G; Todorova, MN | 1 |
| Ding, Y; Li, Y; Sun, H; Wang, J; Wang, M; Wang, X; Wang, Y; Xiao, D; Zhong, Y | 1 |
| Jiang, Z; Liu, J; Peng, H; Tang, Y; Yu, J; Yu, Q; Zhang, H; Zhang, L; Zhao, W | 1 |
| Alalaiwe, A; Cheng, CY; Fang, JY; Lin, CF; Lin, CJ; Lin, YK; Yang, SC | 1 |
| Bai, X; Dang, E; Luo, Y; Wang, G; Yang, L; Yu, C; Zhi, D | 1 |
| Fu, J; Li, P; Wang, Y; Zeng, Z; Zhang, L | 1 |
| Nippel, G; Presto, S; Sammain, A; Schmidt, L; Schölermann, A; Tsianakas, A; von Martial, S | 1 |
| Davis, LS; Flanigan, K; Liles, JE | 1 |
| Fan, X; Li, Z; Liu, X; Wang, G; Yu, C | 1 |
| Lu, C; Xiao, Z; Yu, J; Zhang, Y; Zhao, R | 1 |
| Cao, C; Pang, W; Qi, X; Zhang, S | 1 |
| Jiang, W; Li, B; Li, H; Li, X; Ma, T; Shen, F; Sun, X; Xie, S; Xu, W; Zheng, Q | 1 |
| Chen, Y; Fang, W; He, S; Huang, L; Leng, Y; Li, B; Li, Y; Liu, D; Liu, G; Liu, R; Liu, X; Wang, R; Yang, Z; Ye, C; Yin, H | 1 |
| Huo, R; Li, H; Li, N; Shen, B; Sun, Y; Wu, P; Zhai, T; Zhang, J; Zhou, Z; Zhu, X | 1 |
| Di, T; Li, P; Liang, D; Liu, X; Wang, Y; Zhao, J | 1 |
| Cao, N; Chen, T; Fu, LX; Lu, YH; Yin, B; Zhang, LW; Zhou, PM | 1 |
| Albanesi, C; Avigliano, L; Cavani, A; Madonna, S; Mauriello, A; Melino, G; Palombo, R; Savini, I; Terrinoni, A | 1 |
| Dou, DQ; Hu, XY; Kang, TG; Kuang, HX; Liu, FY; Smith, DC; Zhao, YR | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Psoriasis
| Article | Year |
|---|---|
Total glucosides of paeony for the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials.
Topics: Dermatologic Agents; Glucosides; Glycosides; Humans; Monoterpenes; Paeonia; Psoriasis; Randomized Controlled Trials as Topic | 2019 |
1 trial(s) available for glucose, (beta-d)-isomer and Psoriasis
| Article | Year |
|---|---|
Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial.
Topics: Acitretin; Adult; Alanine Transaminase; Chemical and Drug Induced Liver Injury; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Humans; Keratolytic Agents; Male; Middle Aged; Paeonia; Phytotherapy; Plant Extracts; Plant Roots; Protective Factors; Psoriasis; Severity of Illness Index | 2017 |
33 other study(ies) available for glucose, (beta-d)-isomer and Psoriasis
| Article | Year |
|---|---|
Apurinic/apyrimidinic endonuclease 1 is a key modulator of keratinocyte inflammatory responses.
Topics: Antimicrobial Cationic Peptides; Apoptosis; Cathelicidins; Cell Line; Cyclin D1; Cyclin-Dependent Kinase 4; DNA-(Apurinic or Apyrimidinic Site) Lyase; Epidermis; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoxia-Inducible Factor 1; Inflammation; Interferon Inducers; Interleukin-8; Keratinocytes; NF-kappa B; Poly I-C; Proto-Oncogene Proteins c-akt; Psoriasis; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Toll-Like Receptor 2; Transcriptional Activation; Transfection; Tumor Necrosis Factor-alpha; Up-Regulation; Zymosan | 2009 |
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
Topics: Administration, Oral; Adult; Animals; Anti-Inflammatory Agents; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enterotoxins; Gene Expression Regulation; Humans; Inflammation Mediators; Keratinocytes; Killer Cells, Natural; Leukocytes, Mononuclear; Lipopolysaccharides; Mice; Mice, SCID; Middle Aged; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Psoriasis; RNA, Messenger; Severity of Illness Index; Skin; Skin Transplantation; Thalidomide; Time Factors; Transplantation, Heterologous; U937 Cells; Ultraviolet Rays; Zymosan | 2010 |
Increased superoxide generation by normal granulocytes incubated in sera from patients with psoriasis.
Topics: Ceruloplasmin; Complement Activation; Complement System Proteins; Cytochrome c Group; Female; Granulocytes; Humans; Male; Neutrophils; Oxygen; Psoriasis; Superoxides; Zymosan | 1981 |
Increased respiratory burst activity of monocytes and polymorphonuclear leukocytes in psoriasis.
Topics: Adult; Aged; Cytological Techniques; Female; Humans; Luminescent Measurements; Male; Middle Aged; Monocytes; Neutrophils; Oxygen; Psoriasis; Zymosan | 1982 |
A role for humoral factors in psoriasis.
Topics: Blood Protein Electrophoresis; Cell Count; Cell Division; Chemotaxis; DNA; HeLa Cells; Humans; Lymphocytes; Mitogens; Monocytes; Psoriasis; Zymosan | 1982 |
Increased rate of opsonization of zymosan by serum from patients with psoriasis.
Topics: Humans; Methotrexate; Neutrophils; Opsonin Proteins; Oxygen Consumption; Phagocytosis; Psoriasis; Zymosan | 1982 |
Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.
Topics: Adolescent; Adult; Aged; Chemotactic Factors; Chemotaxis, Leukocyte; Concanavalin A; Female; Humans; Kinetics; Male; Middle Aged; Neutrophils; Psoriasis; Zymosan | 1981 |
Increased polymorphonuclear leukocyte Fc gamma-dependent chemiluminescence in active psoriasis is not related to FcRIII (CD16) receptor expression.
Topics: Adult; Aged; Complement C3b; Female; Humans; Immunoglobulin Fc Fragments; Immunoglobulin G; In Vitro Techniques; Luminescent Measurements; Male; Middle Aged; Neutrophils; Opsonin Proteins; Psoriasis; Receptors, Complement 3b; Receptors, IgG; Respiratory Burst; Zymosan | 1993 |
Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis--measurement of lucigenin-dependent chemiluminescence.
Topics: Acridines; Adult; Complement C5; Complement C5a; Dermatitis, Atopic; Dipeptides; Female; Humans; Luminescent Measurements; Male; Middle Aged; Neutrophils; Oxygen; Psoriasis; Stimulation, Chemical; Tetradecanoylphorbol Acetate; Zymosan | 1986 |
Reactive oxygen species production in circulating polymorphonuclear leukocytes in psoriasis.
Topics: Adult; Aged; Chronic Disease; Female; Humans; Luminescent Measurements; Male; Middle Aged; Neutrophils; Psoriasis; Tetradecanoylphorbol Acetate; Zymosan | 1989 |
[Increase in chemiluminescence induced by receptor-independent stimulation of polymorphonuclear cells from psoriatic patients].
Topics: Adult; Female; Humans; Latex; Luminescent Measurements; Male; Middle Aged; Neutrophils; Oxygen Consumption; Psoriasis; Tetradecanoylphorbol Acetate; Zymosan | 1989 |
Enhanced chemiluminescence production by phagocytosing neutrophils in psoriasis.
Topics: Female; Humans; Luminescent Measurements; Male; Neutrophils; Phagocytosis; Psoriasis; Zymosan | 1988 |
Decreased extracellular release of granule enzymes from in vitro-stimulated polymorphonuclear leukocytes in guttate psoriasis.
Topics: Cells, Cultured; Chemotaxis, Leukocyte; Complement C3; Cytoplasmic Granules; Eczema; Glucuronidase; Humans; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Photosensitivity Disorders; Psoriasis; Zymosan | 1986 |
Mononuclear cell versus monocyte chemotaxis in psoriasis.
Topics: Adult; Chemokines, C; Chemotactic Factors; Chemotaxis, Leukocyte; Humans; Lymphokines; Middle Aged; Monocytes; Psoriasis; Sialoglycoproteins; Zymosan | 1985 |
Stimulus-dependent increased generation of oxygen intermediates in monocytes and polymorphonuclear leukocytes in psoriasis.
Topics: Adolescent; Adult; Aged; Concanavalin A; Female; Humans; Luminescent Measurements; Male; Middle Aged; Monocytes; Neutrophils; Oxygen; Psoriasis; Stimulation, Chemical; Tetradecanoylphorbol Acetate; Zymosan | 1985 |
[Changes in the chemoluminescence behavior of micro- and macrophages in psoriasis: more than just an epiphenomenon?].
Topics: Adolescent; Adult; Aged; Complement C3b; Concanavalin A; Female; Humans; Immunoglobulins; Luminescent Measurements; Macrophages; Male; Middle Aged; Neutrophils; Psoriasis; Tetradecanoylphorbol Acetate; Zymosan | 1985 |
Paeoniflorin inhibits proliferation and migration of psoriatic keratinocytes via the lncRNA NEAT1/miR-3194-5p/Galectin-7 axis.
Topics: Apoptosis; Cell Movement; Cell Proliferation; Galectins; Glucosides; HaCaT Cells; HEK293 Cells; Humans; Keratinocytes; MicroRNAs; Monoterpenes; Psoriasis; RNA, Long Noncoding; Signal Transduction; Up-Regulation | 2022 |
Leucosceptoside A from Devil's Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes.
Topics: Anti-Inflammatory Agents; Cell Line; Glucosides; Harpagophytum; Humans; Inflammation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psoriasis; Signal Transduction | 2021 |
Study on HPLC Fingerprint, Network Pharmacology, and Antifungal Activity of Rumex japonicus Houtt.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Emodin; Glucosides; Humans; Network Pharmacology; Psoriasis; Quercetin; Rumex; Rutin | 2022 |
Total glucosides of Rhizoma Smilacis Glabrae: a therapeutic approach for psoriasis by regulating Th17/Treg balance.
Topics: Animals; Arthritis, Rheumatoid; Biological Assay; Glucosides; Mice; Psoriasis; T-Lymphocytes, Regulatory | 2023 |
Percutaneous absorption of resveratrol and its oligomers to relieve psoriasiform lesions: In silico, in vitro and in vivo evaluations.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Benzofurans; Chemistry, Pharmaceutical; Chemokines; Cytokines; Flavonoids; Glucosides; Inflammation Mediators; Keratinocytes; Mice; Phenols; Plant Extracts; Psoriasis; Resveratrol; Skin Absorption; Stilbenes; Swine | 2020 |
Anti-psoriatic properties of paeoniflorin: suppression of the NF-kappaB pathway and Keratin 17.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cytokines; Down-Regulation; Female; Glucosides; HaCaT Cells; Humans; Imiquimod; Keratin-17; Keratinocytes; Keratins; Mice; Monoterpenes; NF-kappa B; Psoriasis; Signal Transduction | 2020 |
4'-O-β-D-glucosyl-5-O-methylvisamminol ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production by suppressing the NF-κB and MAPK signaling pathways.
Topics: Animals; Chromones; Cytokines; Dermatitis; Glucosides; Imiquimod; Inflammation; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; NF-kappa B; Psoriasis | 2020 |
[Influence of an adjuvant treatment with an emollient containing 10 % urea, ceramides, glycerin und glyceryl glucoside in patients with psoriasis vulgaris].
Topics: Ceramides; Emollients; Glucosides; Glycerol; Humans; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome; Urea | 2021 |
Association of IL-17 Inhibitor and SGLT2 Inhibitor with Candida Pyelonephritis.
Topics: Antibodies, Monoclonal, Humanized; Benzhydryl Compounds; Candida glabrata; Candidiasis, Invasive; Dermatologic Agents; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Insulin Detemir; Liraglutide; Middle Aged; Psoriasis; Pyelonephritis; Recurrence; Sepsis; Sodium-Glucose Transporter 2 Inhibitors; Urinary Tract Infections | 2021 |
Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect.
Topics: Animals; Blotting, Western; Cell Line; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucosides; Guinea Pigs; Humans; Interleukin-22; Interleukins; Lipopolysaccharides; Male; Monoterpenes; p38 Mitogen-Activated Protein Kinases; Paeonia; Phosphorylation; Propranolol; Psoriasis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2017 |
Inhibitory effects of TGP on KGF‑induced hyperproliferation of HaCaT cells via suppression of the p38 MAPK/NF‑κB p65 pathway.
Topics: Cell Line; Cell Proliferation; Fibroblast Growth Factor 7; Glucosides; Humans; Keratinocytes; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Paeonia; Psoriasis; Transcription Factor RelA | 2018 |
Total glucosides of paeony attenuates animal psoriasis induced inflammatory response through inhibiting STAT1 and STAT3 phosphorylation.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Glucosides; Guinea Pigs; Imiquimod; Male; Mice, Inbred BALB C; Nuclear Receptor Subfamily 1, Group F, Member 3; Paeonia; Phosphorylation; Plant Roots; Psoriasis; STAT1 Transcription Factor; STAT3 Transcription Factor | 2019 |
Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents; Cytokines; Female; Glucosides; Imiquimod; Macrophages; Mice, Inbred BALB C; Monoterpenes; Neutrophils; Psoriasis; Skin | 2015 |
Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion.
Topics: Aminoquinolines; Animals; Cell Differentiation; Cell Proliferation; Cell Survival; Cytokines; Gene Expression Regulation; Glucosides; Imiquimod; Keratinocytes; Mice; Monoterpenes; Nuclear Receptor Subfamily 1, Group F, Member 3; Phosphorylation; Psoriasis; RNA, Messenger; Skin; STAT3 Transcription Factor; Th17 Cells | 2016 |
Paeoniflorin suppresses inflammatory response in imiquimod-induced psoriasis-like mice and peripheral blood mononuclear cells (PBMCs) from psoriasis patients.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Glucosides; Humans; Imiquimod; Inflammation Mediators; Leukocytes, Mononuclear; Male; Mice; Mice, Inbred BALB C; Monoterpenes; Psoriasis; Random Allocation | 2016 |
Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.
Topics: Acanthosis Nigricans; Aminoquinolines; Animals; Cell Differentiation; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Glucosides; Humans; Imiquimod; Immunohistochemistry; Inflammation; Interleukin-22; Interleukins; Keratinocytes; Lipids; Luteolin; Mice, Inbred C57BL; Oxidation-Reduction; Phenotype; Protein Transport; Psoriasis; Signal Transduction; STAT3 Transcription Factor | 2016 |
Studies on the anti-psoriasis constituents of Oplopanax elatus Nakai.
Topics: Drugs, Chinese Herbal; Glucosides; Lignans; Magnetic Resonance Spectroscopy; Molecular Structure; Oplopanax; Plant Roots; Plant Stems; Psoriasis | 2009 |